Data characterising long-term survivors (LTS) with human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer (MBC) are limited. This analysis describes LTS using registHER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback